Bayer and Monsanto announced that they signed a definitive merger agreement under which Bayer will acquire Monsanto for $128 per share in an all-cash transaction. Monsanto's Board of Directors, Bayer's Board of Management and Bayer's Supervisory Board have unanimously approved the agreement. The offer represents a premium of 44% to Monsanto's closing share price on May 9, 2016, the day before Bayer's first written proposal to Monsanto.
Morrow Sodali is serving as the proxy solicitor for Monsanto.
Related News
How to Prep a CEO For the Scrutiny of Life Post-IPO: ECM Watch
25 August 2025
Sodali & Co Appoints Emily Wei and Hasib Nasirullah as Co-Leads of Global Sustainability Practice
19 August 2025
Sodali & Co Strengthens U.S. Corporate Governance Advisory with Appointment of Matthew Vahidi as Managing Director
13 August 2025
Entering a new phase of shareholder activism
04 August 2025
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right